Nelson J L, Ostensen M
Program in Immunogenetics, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Rheum Dis Clin North Am. 1997 Feb;23(1):195-212. doi: 10.1016/s0889-857x(05)70323-9.
Amelioration of rheumatoid arthritis (RA) occurs in about three quarters of pregnancies. Most women who improve experience initial relief in the first trimester. RA almost invariably recurs within 3 to 4 months of delivery. The effect of pregnancy upon the risk of first developing RA is similar in some respects but also differs from that observed in women with established disease. Analogous to women with established disease, the chance of a woman first developing RA is significantly reduced during pregnancy but increased in the first year post partum; thereafter risk is decreased. There is no indication of any adverse effects of RA on pregnancy outcome. Although limited, some medications can be used during pregnancy and during lactation without jeopardizing the well-being of the fetus.
约四分之三的孕期类风湿关节炎(RA)病情会有所改善。大多数病情改善的女性在孕早期开始出现症状缓解。RA几乎总会在分娩后3至4个月内复发。怀孕对首次患RA风险的影响在某些方面与之相似,但也与患已有疾病女性的情况有所不同。与患已有疾病的女性类似,女性首次患RA的几率在孕期显著降低,但在产后第一年增加;此后风险降低。没有迹象表明RA对妊娠结局有任何不良影响。虽然有限,但一些药物在孕期和哺乳期使用时不会危及胎儿健康。